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Abstract
Background: In an attempt to prepare scaffolds with porosity and compressive strength as high as possible, we
prepared porous β-tricalcium phosphate (TCP) scaffolds and coated them with regenerative medicine-grade
gelatin. The effects of the gelatin coating on the compressive strength and in vivo osteoblast compatibility
were investigated.
Methods: Porous β-TCP scaffolds were prepared and coated with up to 3 mass% gelatin, and then subjected
to thermal cross-linking. The gelatin-coated and uncoated scaffolds were then subjected to compressive
strength tests and implantation tests into bone defects of Wistar rats.
Results: The compressive strength increased by one order of magnitude from 0.45 MPa for uncoated to
5.1 MPa for gelatin-coated scaffolds. The osteoblast density in the internal space of the scaffold increased by
40 % through gelatin coating.
Conclusions: Coating porous bone graft materials with gelatin is a promising measure to enhance both
mechanical strength and biomedical efficacy at the same time.
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Background
Porous hydroxyapatite (HA) and β-tricalcium phosphate
(β-TCP) have long been clinically used for bone grafts
because they enable perfusion of cells and other factors
necessary for bone regeneration and because they allow
bone ingrowth [1–3]. There have been a large number of
works on the effect of porous structures on biological
efficacy. For example, pores larger than 100 mm are
essential for bone ingrowth into HA scaffolds [4, 5], and
larger pores facilitate faster bone ingrowth [6]. There-
fore, much effort has been devoted to the fabrication of
scaffolds with pores as large as possible, and various pro-
cessing techniques have been reported, although most of
them were attempted on HA [7, 8]. Examples include
freeze casting [8–10], sponge templating [11, 12], gel
casting [13], particle templating [14, 15], whisker sinter-
ing [16], robocasting [17], extrusion deposition [18], and
slurry foaming [19].
Although larger pores and porosities are favorable for
faster bone ingrowth, they deteriorate the mechanical
strength of the scaffolds. From a practical viewpoint, the
compressive strength needs to be higher than approxi-
mately 1.0 MPa in order to avoid collapsing of the scaf-
folds during the handling for implantation. Therefore,
there is a trade-off between the mechanical strength and
the porosity. One of the promising methods to reinforce
scaffolds without lowering its porosity or biomedical effi-
cacy is to coat the scaffolds with biocompatible polymers
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because the infiltration of polymers into the microcracks
of the scaffolds reduces the fracture origin [20]. The
most widely used polymers are poly(lactic acid)- and
poly(caprolactone)-based polymers [14–16, 21–25].
Others include glycerol sebacate [26], gelatin [14, 27],
and collagen [28]. When scaffolds were coated with
poly(lactic acid) or poly(caprolactone), the compressive
strength generally increased [21–25]. However, the ef-
fects of those coatings on the biomedical efficacy of
the scaffolds differ from report to report. In some
cases, in vitro differentiation of MC3T3-E1 preosteo-
blast cells and bone marrow stroma cells were pro-
moted [21], whereas in other cases, the initial
attachment and proliferation were suppressed [16, 23, 26].
Biomedical evaluation was not quantitatively described
in some reports [22, 25]. Some studies reported the
in vitro cytocompatibility of collagen-coated scaffolds,
in which the proliferation and differentiation of
MG63 were enhanced [28] and the differentiation of
rat-originated osteoblasts was promoted [29]. Still,
in vivo evaluation of those polymer-coated scaffolds
has been very scarce.
One of the present authors (SY) has developed
endotoxin-free gelatin for regenerative medicine [30].
Gelatin is an inherently cytocompatible substance, and
its mechanical strength can be enhanced by thermal
cross-linking. Therefore, gelatin is a promising substance
for the reinforcing coating of porous ceramic scaffolds.
In the present work, we first reinforced porous β-TCP
scaffolds by gelatin coating, followed by thermal cross-
linking. Then, the resultant scaffolds were evaluated for
in vivo cytocompatibility from animal implantation tests.
Methods
Preparation of porous β-TCP blocks
Porous β-TCP scaffolds were prepared in our laboratory
by sintering porous green bodies in the following man-
ner. Commercial β-TCP powder (β-TCP −100, Taihei
Chemical Industrial Co., Ltd., Osaka, Japan) was ground
with an automatic agate mortar for 30 min to crush any
coarse agglomeration. Then, 36.84 g of the β-TCP pow-
der was added to the dispersion medium, which was
prepared by dissolving 0.325 g of polyvinyl alcohol
(polymerization degree 2000) and 3.0 g of an ammonium
polyacrylate-based dispersant (Kaocera 2000, Kao Corp.,
Tokyo, Japan). The mixture was ball milled for 12 h.
MgO (0.37 g) was added to suppress the phase transition
during sintering, and the mixture was ball milled again
for 1 h to prepare a well-dispersed slurry. The solid con-
tent of the slurry was approximately 45 vol%.
A foaming agent (6 mL, EMAL D-3-D, sodium poly-
oxyethylene alkyl ether sulfate, Kao Corp.) was added to
30 g of the slurry. The mixed slurry was then whisked
with a kitchen blender. The whisked slurry was poured
into a polymer mold approximately 40 × 40 × 50 mm in
volume, frozen with liquid nitrogen vapor, and then ly-
ophilized to give a porous green body. The green body
was sintered at 1473 K for 12 h in ambient air to obtain
β-TCP scaffolds. The porosity of the as-sintered scaffolds
was 92 % as measured by the Archimedes method.
Gelatin coating
Two kinds of gelatin were used: reagent-grade gelatin
(Wako Pure Chemicals Ind., Ltd.) for the preliminary ex-
periments and regenerative medicine-grade gelatin (RM-
100, Jellice Co., Ltd.) for the final experiments. Porous
β-TCP scaffolds were immersed in aqueous solutions
containing 0.5, 1.0, or 2.0 mass% gelatin for 30 s, taken
out, and the redundant solution was removed by wiping
the blocks with paper towels. The β-TCP blocks bearing
gelatin solutions were cooled in a refrigerator at 253 K
overnight and then dried at room temperature in a vac-
uum. The dried, gelatin-coated β-TCP scaffolds were
subjected to heat treatments in a vacuum to obtain
cross-linked gelatin. The cross-linking temperatures
were 373, 393, 413, and 433 K, and the duration was
12 h.
Characterization of gelatin-coated β-TCP
The crystalline phase of the sintered scaffold was ascer-
tained to be β-TCP by X-ray diffractometry (data not
shown). The gelatin content was determined by thermo-
gravimetry. The compressive strength of the β-TCP
scaffolds, both gelatin-coated and uncoated, using sam-
ples approximately 10 × 10 × 20 mm in size was mea-
sured on an Aikoh testing machine at a crosshead rate
of 1.0 mm/min. The compressive strength was defined
as the maximum stress before the strain exceeded 10 %
of the specimen length. The microstructure was observed
with a scanning electron microscope (SEM, e-SEM,
Shimadzu Rika Corp., Tokyo, Japan).
Animal implantation test
The animal implantation tests were conducted under the
permission of the Ethics Commission on the Animal
Tests, Kanagawa Dental College (No. 2014-8.11-1). Male
Wistar rats, 7 weeks of age, were used. A bone defect
5.2 mm in diameter was made in the cranial bone of
each rat with a dental drill. Either a gelatin-coated or
uncoated β-TCP block (samples E and O in Table 1) was
implanted into the defect, and the skin was sutured.
Each group contained nine rats. After 2 weeks, the ex-
perimental sections were retrieved, sliced into thin sec-
tions 3.5 μm in average thickness, decalcified, and
stained with hematoxylin–eosin. One thin section was
prepared from each rat. From each thin section, pictures
from five fields of view were taken, and the number of
osteoblasts in a 100 × 100 μm area in the internal space
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of the scaffold was counted. The statistical significance
of the osteoblast density was examined by Student’s t
test.
Results
Physical properties of the β-TCP scaffolds
Table 1 summarizes the preparation conditions and
physical properties of the gelatin–β-TCP scaffolds. The
contents of the gelatin coatings varied from 0.6 to 3.0
mass%, depending on the gelatin concentration in the
coating solution. The decrease in porosity after the gel-
atin coating was small, and all the scaffolds had porosi-
ties higher than 90 %.
A Weibull plot of the compressive strengths of the
scaffolds is shown in Fig. 1, and the typical stress–strain
curves of uncoated sample O and gelatin-coated sample
F are shown in Fig. 2. The average compressive strength,
standard deviation, and Weibull coefficient of each sam-
ple are given in Table 1. The enhancement of the com-
pressive strength by the gelatin coating was remarkable;
just 3.0 mass% of gelatin increased the compressive
strength by one order of magnitude. The compressive
strength increased with increasing gelatin content
(comparing samples O, A, B, and F) and with increas-
ing cross-linking temperature (comparing samples C,
D, E, and F). Cross-linking, however, seemed to ter-
minate at 413 K because there was no significant dif-
ference in the compressive strength between samples
E and F. In spite of the increase in the compressive
strength, the Weibull coefficient did not increase
upon gelatin coating.
The microstructures of the uncoated and gelatin-
coated scaffolds are shown in Fig. 3. The pore diameter
seemed to be quite uniform, ranging from 200 to
500 μm. The gelatin layer was visible in the interconnec-
tions of the pores in the coated scaffold [Fig. 3c]. Under
a higher magnification, infiltration of gelatin in the
coated scaffolds was observed because pores smaller
than a few micrometers were buried and the surface be-
came smoother [Fig. 3d].
In vivo tests
Figure 4 shows histological photographs of the im-
planted gelatin-coated [Fig. 4a] and uncoated [Fig. 4b]
scaffolds. In both pictures, white areas correspond to
unresorbed β-TCP and blue dots correspond to osteo-
blasts. Newly formed bone was not yet recognized in
either picture; however, the osteoblast density seemed
Fig. 1 Weibull plots of the compressive strengths of uncoated and
gelatin-coated scaffolds
Fig. 2 Examples of stress–strain curves of uncoated sample O and
gelatin-coated sample F
Table 1 Preparation conditions and physical properties of gelatin-β-TCP scaffolds
Sample Gelatin content (mass%) Cross-link temp (K) Porosity (%) Average compressive strength σ (MPa) Standard deviation Weibull coefficient
O 0.0 − 92 0.45 0.1 4.4
A 0.6 433 92 3.36 1.3 2.9
B 1.4 433 91 3.38 1.0 3.2
C 3.0 373 91 3.42 1.1 3.0
D 3.0 393 91 3.59 1.1 2.9
E 3.0 413 91 5.14 1.2 4.2
F 3.0 433 91 5.04 1.6 2.9
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to be higher near the gelatin-coated scaffold. The
osteoblast density analysis is shown in Fig. 5. The
osteoblast density around the gelatin-coated scaffolds
(sample E) was higher than that around the uncoated
scaffolds (sample O) by approximately 40 % with stat-
istical significance: from 4 × 105 cells/cm3 for the un-
coated scaffolds (O) to 5.6 × 105 cells/cm2 for the
gelatin-coated scaffolds (E).
Discussion
The present gelatin coating effectively reinforced porous
β-TCP scaffolds. Generally, the fracture of brittle mate-
rials originates from the weakest crack tip where the
applied stress is concentrated. The applied stress (σ) is
concentrated at the crack tip to a value of σm depending
a b
c d
Fig. 3 SEM pictures of a, b uncoated sample O and c, d gelatin-coated sample F
a
b
Fig. 4 Histological pictures around implanted scaffolds: a uncoated
sample O and b gelatin-coated sample E. β-TCP and OB stand for
unresorbed β-TCP and osteoblast, respectively
Fig. 5 Osteoblast densities in the internal space of uncoated sample
O and gelatin-coated sample E. *p < 0.05
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on the depth (c) and curvature radius (ρ) of the crack








The fracture starts when σm exceeds the theoretical
strength of the material, σth. Therefore, the mechanical
strength of a material increases as the cracks become
less sharp and shallow. As shown in Fig. 3, the coated
gelatin seemed to infiltrate into the microcracks of the
framework of the scaffolds and flatten the framework
surface, which should enhance the compressive strength
of the scaffolds.
Presently, porous bone augmentation materials clinic-
ally used in Japan are fabricated so that the material pos-
sesses porosity as high as possible while retaining
minimal compressive strength. To the authors’ know-
ledge, the lowest compressive strength of clinically used
β-TCP scaffolds is 0.9 MPa (Osferion, Olympus Terumo
Biomaterials, Tokyo, Japan) and its porosity is 75 %. In
contrast, we have succeeded in preparing β-TCP scaf-
folds whose porosity and compressive strength are far
higher than those of the commercial scaffolds. If the
requisite minimum strength for bone augmentation
material is approximately 1.0 MPa, there is a room to
further increase the porosity.
In addition to reinforcing β-TCP scaffolds, the gel-
atin coating increased the osteoblast density near the
scaffolds. This seems natural because gelatin has long
been known to be a cytocompatible material. In the
present study, however, 2 weeks of implantation may
have been too short to observe the rates of the new
bone formation within the pores of the scaffolds and
of the resorption of those. Those studies will have to
be conducted to more precisely and quantitatively as-
sess the effect of gelatin coating. At least, still, a
higher osteoblast density may imply faster new bone
formation.
On the other hand, it has been well established that
the dissolution of β-TCP promotes the migration of
osteoclasts and osteoblasts [31], and calcium ions re-
leased from β-TCP may promote differentiation of oste-
oblasts [32, 33]. The gelatin coating may slow the
dissolution of β-TCP, depending on the amount and
thickness of the coating. Therefore, an increase in the
osteoblast density alone does not guarantee fast bone re-
generation. Although further studies are necessary to
elucidate the biomedical efficacy of gelatin coating, this
work is the first to report the in vivo effect of the gelatin
coating on osteoblast density.
Hydrolysis of gelatin gives peptide oligomers. Among
those, tripeptides, which consist of glycine and two other
amino acids, have been proven to promote osteoblast
differentiation [31] and in vivo bone healing [34, 35].
There is a possibility, therefore, that the coated gelatin is
hydrolyzed to tripeptides, thus further promoting bone
formation.
Conclusions
Porous β-TCP scaffolds with approximately 90 % poros-
ity were prepared and coated with gelatin. The gelatin
coating and subsequent thermal cross-linking increased
the compressive strength by one order of magnitude.
The highest compressive strength attained was 5.1 MPa.
The gelatin-coated and uncoated scaffolds were im-
planted into bone defects of the cranial bones of
Wistar rats for 2 weeks. The osteoblast density in the
internal space of the scaffold was enhanced by 40 %
by gelatin coating, implying the possibility of faster
bone formation.
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